Literature DB >> 22697487

Tissue engineering: selecting the optimal fixative for immunohistochemistry.

Sabine Koch1, Nadine Stappenbeck, Christian G Cornelissen, Thomas Cormac Flanagan, Petra Mela, Jörg Sachweh, Benita Hermanns-Sachweh, Stefan Jockenhoevel.   

Abstract

BACKGROUND: In the immunohistochemical analysis of tissue-engineered structures, aggressive treatments for fixation and antigen retrieval can impair the quality of specimen staining and visualization. HYPOTHESIS: We hypothesized that the adequate choice of fixative and antigen-retrieval method might improve the quality of immunohistochemical staining.
METHODS: Tissue-engineered vascular grafts were fixed using formalin, Carnoy's, or HOPE(®) fixative. Antigen retrieval was performed where necessary and samples from each group were stained using hematoxylin and eosin to assess overall tissue preservation. For a set of proteins relevant to cardiovascular tissue development, immunohistochemical staining was applied to formalin-, Carnoy's-, and HOPE-fixed specimens to allow a comparative analysis.
RESULTS: In tissue-engineered constructs, antigen retrieval methods necessary after formalin fixation led to significant destruction of the overall tissue structure. Carnoy's fixation resulted in good overall tissue preservation and adequate results for immunohistochemical staining of alpha-smooth muscle actin (α-SMA), vimentin, type I collagen, elastin, and laminin. HOPE fixative led to a loosened tissue structure and a swollen appearance but showed adequate results for staining against type III collagen and elastin. Formalin fixation without antigen retrieval led to inadequate visualization of α-SMA, vimentin, type I- and type III collagen, and laminin.
CONCLUSION: Based on the present study, we recommend that Carnoy's fixative is employed for the preservation of tissue-engineered constructs to allow immunohistochemical analysis of type I- and type III collagen, elastin, laminin, α-SMA, and vimentin. However, it is clear that the technique requires optimization based on the particular tissue engineering application.

Entities:  

Mesh:

Year:  2012        PMID: 22697487     DOI: 10.1089/ten.TEC.2012.0159

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  2 in total

1.  Reply to the comment of Drs Goldman and Vollmer.

Authors:  Thorben Nietner; Tiantom Jarutat; Alfred Mertens
Journal:  Virchows Arch       Date:  2013-08-24       Impact factor: 4.064

2.  From In Vitro to Perioperative Vascular Tissue Engineering: Shortening Production Time by Traceable Textile-Reinforcement.

Authors:  Saurav Ranjan Mohapatra; Elena Rama; Christoph Melcher; Tobias Call; Miriam Aischa Al Enezy-Ulbrich; Andrij Pich; Christian Apel; Fabian Kiessling; Stefan Jockenhoevel
Journal:  Tissue Eng Regen Med       Date:  2022-10-06       Impact factor: 4.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.